Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma

被引:0
|
作者
N Nohata
T Hanazawa
T Kinoshita
A Inamine
N Kikkawa
T Itesako
H Yoshino
H Enokida
M Nakagawa
Y Okamoto
N Seki
机构
[1] Chiba University Graduate School of Medicine,Department of Functional Genomics
[2] Chiba University Graduate School of Medicine,Department of Otorhinolaryngology/Head and Neck Surgery
[3] Graduate School of Medical and Dental Sciences,Department of Urology
[4] Kagoshima University,undefined
来源
British Journal of Cancer | 2013年 / 108卷
关键词
cell cycle arrest; apoptosis; HNSCC;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1648 / 1658
页数:10
相关论文
共 50 条
  • [1] Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma
    Nohata, N.
    Hanazawa, T.
    Kinoshita, T.
    Inamine, A.
    Kikkawa, N.
    Itesako, T.
    Yoshino, H.
    Enokida, H.
    Nakagawa, M.
    Okamoto, Y.
    Seki, N.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1648 - 1658
  • [2] Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma
    T Kinoshita
    N Nohata
    T Hanazawa
    N Kikkawa
    N Yamamoto
    H Yoshino
    T Itesako
    H Enokida
    M Nakagawa
    Y Okamoto
    N Seki
    British Journal of Cancer, 2013, 109 : 2636 - 2645
  • [3] Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma
    Kinoshita, T.
    Nohata, N.
    Hanazawa, T.
    Kikkawa, N.
    Yamamoto, N.
    Yoshino, H.
    Itesako, T.
    Enokida, H.
    Nakagawa, M.
    Okamoto, Y.
    Seki, N.
    BRITISH JOURNAL OF CANCER, 2013, 109 (10) : 2636 - 2645
  • [4] miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma
    Nohata, Nijiro
    Sone, Yaeko
    Hanazawa, Toyoyuki
    Fuse, Miki
    Kikkawa, Naoko
    Yoshino, Hirofumi
    Chiyomaru, Takeshi
    Kawakami, Kazumori
    Enokida, Hideki
    Nakagawa, Masayuki
    Shozu, Makio
    Okamoto, Yoshitaka
    Seki, Naohiko
    ONCOTARGET, 2011, 2 (1-2) : 29 - 42
  • [5] Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines
    Enzenhofer, Elisabeth
    Kadletz, Lorenz
    Stanisz, Isabella
    Kotowski, Ulana
    Seemann, Rudolf
    Schmid, Rainer
    Thurnher, Dietmar
    Heiduschka, Gregor
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (05): : 900 - 907
  • [6] SEC11A contributes to tumour progression of head and neck squamous cell carcinoma
    Shen, Hailong
    Yi, Fangzheng
    Ding, Zhao
    Liu, Weiwei
    Liu, Ping
    Wang, Zixi
    Liu, Shixian
    Liu, Yehai
    Li, Dapeng
    HELIYON, 2023, 9 (04)
  • [7] Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma
    Suchanti, Surabhi
    Stephen, Bjorn J.
    Awasthi, Sonali
    Awasthi, Sudhir K.
    Singh, Gyanendra
    Singh, Abhijeet
    Mishra, Rajeev
    EPIGENOMICS, 2022, 14 (05) : 279 - 293
  • [8] MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9
    Wang, Ling
    Gao, Wen
    Hu, Fan
    Xu, Zhiyang
    Wang, Fuqiang
    FEBS LETTERS, 2014, 588 (24) : 4527 - 4535
  • [9] Targeting Wee1 kinase to suppress proliferation and survival of cisplatin-resistant head and neck squamous cell carcinoma
    Yang, Zejia
    Liao, Jipei
    Lapidus, Rena G.
    Fan, Xiaoxuan
    Mehra, Ranee
    Cullen, Kevin J.
    Dan, Hancai
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (04) : 469 - 478
  • [10] Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma
    Chen, Chi-Yuan
    Chiou, Shih-Hwa
    Huang, Chih-Yang
    Jan, Chia-Ing
    Lin, Shu-Chun
    Hu, Wen-Yuan
    Chou, Shiu-Huey
    Liu, Chung-Ji
    Lo, Jeng-Fan
    JOURNAL OF PATHOLOGY, 2009, 219 (03) : 347 - 355